References
Residual fluid after IV infusion drug administration: risk of suboptimal dosing
We are writing in response to the article by Andrew Barton and board members of the UK's National Infusion and Vascular Access Society (NIVAS). ‘Intravenous infusion drug administration: flushing guidance’ (Barton et al, 2019). We contend that there is substantial evidence to support concern regarding this issue (Rout et al, 2019), and the NIVAS guidelines cite several recent publications from the UK that have raised the alarm regarding nursing management of undelivered therapeutic fluid (Cooper et al, 2018; Cousins, 2018; Furniss et al, 2018).
It is evident from research that has been conducted into intravenous intermittent infusions that a gap in clinical practice exists regarding the optimal management of residual fluid (Hoefel et al, 2008; Chan et al, 2013; Lam et al, 2013; Cooper et al, 2018; Furniss et al, 2018; Morrow, 2018; Thoele et al, 2018), and it is indeed the place of NIVAS to offer expert consensus (Barton et al, 2019). However, these guidelines underplay the significance of underdosing from non-delivery of residual volume.
Register now to continue reading
Thank you for visiting British Journal of Nursing and reading some of our peer-reviewed resources for nurses. To read more, please register today. You’ll enjoy the following great benefits:
What's included
-
Limited access to clinical or professional articles
-
Unlimited access to the latest news, blogs and video content